Con: should asymptomatic patients with moderate-to-severe OSA be treated? | European Respiratory Society

Article Information

vol. 15 no. 1 11-14

DOI

https://doi.org/10.1183/20734735.0347-2018

Published By

European Respiratory Society

Print ISSN

Online ISSN

History

Published online March 1, 2019.

Copyright & Usage

Copyright ©ERS 2019 Breathe articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.

Author Information

Andrew Vakulin1,2,
Ching Li Chai-Coetzer1,3 and
R. Doug McEvoy1,3 ⇑

¹Adelaide Institute for Sleep Health: A Flinders Centre of Research Excellence, College of Medicine and Public Health, Flinders University, Adelaide, Australia
²The NHMRC Centre of Research Excellence, NEUROSLEEP, Woolcock Institute of Medical Research, The University of Sydney, Sydney, Australia.
³Respiratory and Sleep Service, Southern Adelaide Local Health Network, Adelaide, Australia

E-mail: doug.mcevoy{at}flinders.edu.au

Article usage

Article usage: February 2019 to May 2020

	Abstract	Full	Pdf
Feb 2019	0	3	1
Mar 2019	10	868	189
Apr 2019	6	191	70
May 2019	2	142	55
Jun 2019	4	43	21
Jul 2019	3	70	32
Aug 2019	3	41	6
Sep 2019	1	28	6
Oct 2019	2	31	14
Nov 2019	3	50	12
Dec 2019	2	30	15
Jan 2020	4	54	10
Feb 2020	5	45	10
Mar 2020	3	38	12
Apr 2020	3	38	14
May 2020	3	46	16

Altmetrics

Vol 15 Issue 1 Table of Contents

Breathe: 15 (1)

Print

Full Text (PDF)

Subjects

Sleep medicine

More in this TOC Section

Editorials

Show more Editorials

Pro/con debate

Pro: treatment of asymptomatic patients with moderate-to-severe OSA

Show more Pro/con debate

Related Articles